Finding the Answer: How Doctors Identify CAPS

When a patient is in the ICU with rapidly failing organs, doctors must act like detectives. To diagnose Catastrophic Antiphospholipid Syndrome (CAPS), they look for a specific pattern of “thrombotic storm” while working to rule out other emergencies that look almost identical. This process is complex because the very antibodies that cause CAPS can also “scramble” the standard lab tests doctors use to monitor treatment.

The Diagnostic Checklist

Doctors use a set of international criteria to classify CAPS. While these help confirm the diagnosis, the medical team will often start treatment before every box is checked because of how fast the disease moves ^[1].

• Three or More Organs: Damage or clots must appear in at least three different organ systems (such as the kidneys, lungs, and brain) ^[2].
• Rapid Timing: These symptoms must develop simultaneously or within less than one week ^[2][3].
• Small Vessel Clots: Ideally, a biopsy (a small tissue sample) would show clots in the tiny blood vessels (microvascular thrombosis). However, in the ICU, a patient is often too unstable for a biopsy, or the risk of bleeding is too high ^[4]. Treatment should never be delayed just to wait for a biopsy ^[1].
• Antibody Presence: Lab tests must confirm the presence of antiphospholipid antibodies. APS laboratory classification generally requires persistent positivity on two tests at least 12 weeks apart, while acute infection and critical illness can affect results. An initial positive result can support urgent treatment but does not by itself establish chronic APS or predict recurrence ^[2].

The “Big Three” Antibodies

The diagnosis relies on finding specific “self-attacking” antibodies in the blood. These include:

1. Lupus Anticoagulant (LA): Despite the name, this can appear in people without Lupus. It is a major risk factor for clotting ^[5].
2. Anticardiolipin (aCL): Measured as IgG or IgM types ^[6].
3. Anti-β2-Glycoprotein I (anti-β2GPI): Another critical marker of the syndrome ^[5].

Patients who test positive for all three are called “triple positive”, which is a higher-risk profile for thrombotic APS, but it is not a diagnosis or guarantee of CAPS ^[7].

Why Platelets Drop

A hallmark of CAPS is thrombocytopenia, or a low platelet count. Platelets are the cells that help your blood clot. In CAPS, your count drops because:

• Consumption: So many clots are forming throughout the body that the supply of platelets is used up ^[8].
• Destruction: The antibodies may directly attack and destroy platelets ^[9].
  While common, low platelets can result from sepsis, bleeding, or other critical illness and are not a stand-alone proof of CAPS ^[10].

Sorting Through the “Look-alikes”

Several other conditions can mimic CAPS. Doctors must quickly exclude these because the treatments are different:

• TTP (Thrombotic Thrombocytopenic Purpura): This also causes tiny clots. Doctors help assess this with a test called ADAMTS13 ^[11].
• HIT (Heparin-Induced Thrombocytopenia): An allergy to the blood thinner heparin. Doctors use an anti-PF4 test to check for this ^[12].
• DIC (Disseminated Intravascular Coagulation): Widespread clotting often caused by severe infection (sepsis). Doctors check clotting markers like fibrinogen and D-dimer ^[13].
• Malignant Hypertension: Extremely high blood pressure that damages organs. Doctors will check the back of the eyes (funduscopic exam) for signs of pressure damage ^[12].

These tests contribute to evaluation but do not alone rule out these conditions, and clinicians often begin empiric treatment for immediately dangerous alternatives while tests are pending.

The “Unreliable” Lab Test

One of the most confusing parts of CAPS for families is how doctors monitor the blood thinner heparin.
Normally, doctors use a test called the aPTT to see if heparin is working. However, the Lupus Anticoagulant antibody can interfere with this test, making the aPTT result overestimate heparin effect, even though the patient remains prothrombotic ^[14][15].

To get an accurate reading, the medical team may use a more specialized test called the chromogenic anti-Xa assay. This test bypasses the interference from the antibodies to provide a better estimate of active drug, although the ICU team selects and interprets the assay using the clinical context and antithrombin levels ^[16][17].